Search results
The Biggest Risk Factor for Bladder Cancer Has Nothing to Do With Pee, Diet, or Genes
Verywell Health via Yahoo News· 4 days agoBladder cancer is common, but one of the biggest risk factors is something you can quit—cigarettes....
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 2 days agoThe study, focusing on patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC),...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 days agoMerck and Moderna released “extremely impressive” positive data from a mid-stage trial of the...
KUTV reporter diagnosed with early-stage pancreatic cancer credits check-up
KUTV Salt Lake City· 4 days agoThe earlier cancer is caught, the better the chance of it being treated. Pancreas cancer is...
... 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer - ALX Oncology Holdings...
Benzinga· 6 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt,
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal ...
Benzinga· 5 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival ...
'I was quoted £700 for a week's travel insurance due to cancer'
Daily Express· 15 hours agoThousands of people with cancer face missing out on summer holidays because they cannot find...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
The Motley Fool via AOL· 4 days agoOne of those therapies, Padcev, recently earned approval from the Food and Drug Administration (FDA) to treat newly diagnosed bladder cancer patients. New ...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 5 days agoClinical-stage cell therapy company Shanghai Grit Biotechnology (GRIT) has formed a strategic...
In his mid-70s, Terry Bradshaw is still on stage and says, ‘I’m in my prime.’
Fort Worth Star-Telegram via Yahoo News· 2 days agocancer free. This is my second or third year free. I got through with one treatment, so thank God I...